Jenburkt Pharmaceuticals Q4 Results

  • BSE: 524731
  • NSE: -
  • ISIN: INE354A01013
  • Sector: Biotechnology & Drugs
BSE
1,234.972.55 (6.24%)
Volume3.26 K
Updated: Mon 25 Nov, 2024 | 15:29:56
NSE
This stock is not traded on NSE
Today: 1,162.45
1,260.00
52-Wk: 643.20
1,375.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Jenburkt Pharmaceuticals Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 38.8434.57-%35.20-%
    Selling/ General/ Admin Expenses Total 10.3810.45-%9.12-%
    Depreciation/ Amortization 0.620.58-%0.59-%
    Other Operating Expenses Total 10.409.03-%9.47-%
    Total Operating Expense 29.6128.17-%28.30-%
    Operating Income 9.236.40-%6.90-%
    Net Income Before Taxes 10.377.76-%8.08-%
    Net Income 7.885.43-%6.35-%
    Diluted Normalized EPS 17.8611.84-%16.36-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts